State of Alaska Department of Revenue’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.23M | Sell |
10,233
-3,123
| -23% | -$736K | 0.03% | 466 |
|
|
2026
Q1 | $2.67M | Sell |
13,356
-293
| -2% | -$58K | 0.03% | 567 |
|
|
2025
Q4 | $2.58M | Buy |
13,649
+2,757
| +25% | +$530K | 0.03% | 580 |
|
|
2025
Q3 | $1.93M | Sell |
10,892
-586
| -5% | -$87.1K | 0.02% | 741 |
|
|
2025
Q2 | $1.3M | Buy |
11,478
+1,008
| +10% | +$108K | 0.01% | 913 |
|
|
2025
Q1 | $1.1M | Sell |
10,470
-269
| -3% | -$30.4K | 0.01% | 964 |
|
|
2024
Q4 | $1.15M | Buy |
10,739
+314
| +3% | +$35.5K | 0.01% | 984 |
|
|
2024
Q3 | $1.04M | Buy |
10,425
+510
| +5% | +$51.3K | 0.01% | 1044 |
|
|
2024
Q2 | $835K | Sell |
9,915
-70
| -0.7% | -$5.57K | 0.01% | 1103 |
|
|
2024
Q1 | $729K | Sell |
9,985
-99
| -1% | -$7.3K | 0.01% | 1206 |
|
|
2023
Q4 | $720K | Sell |
10,084
-74
| -0.7% | -$4.37K | 0.01% | 1180 |
|
|
2023
Q3 | $608K | Sell |
10,158
-639
| -6% | -$42.1K | 0.01% | 1225 |
|
|
2023
Q2 | $778K | Sell |
10,797
-193
| -2% | -$14.5K | 0.01% | 1118 |
|
|
2023
Q1 | $808K | Sell |
10,990
-185
| -2% | -$13.2K | 0.01% | 1093 |
|
|
2022
Q4 | $746K | Sell |
11,175
-6,626
| -37% | -$431K | 0.01% | 1139 |
|
|
2022
Q3 | $956K | Sell |
17,801
-2,642
| -13% | -$155K | 0.01% | 940 |
|
|
2022
Q2 | $1.14M | Buy |
20,443
+1,803
| +10% | +$102K | 0.01% | 885 |
|
|
2022
Q1 | $1.31M | Sell |
18,640
-328
| -2% | -$23.8K | 0.01% | 856 |
|
|
2021
Q4 | $1.83M | Sell |
18,968
-537
| -3% | -$49.6K | 0.02% | 757 |
|
|
2021
Q3 | $1.7M | Buy |
19,505
+15,360
| +371% | +$1.19M | 0.02% | 791 |
|
|
2021
Q2 | $339K | Sell |
4,145
-28
| -0.7% | -$2.33K | ﹤0.01% | 1560 |
|
|
2021
Q1 | $396K | Sell |
4,173
-16
| -0.4% | -$1.51K | ﹤0.01% | 1500 |
|
|
2020
Q4 | $259K | Sell |
4,189
-202
| -5% | -$11.5K | ﹤0.01% | 1557 |
|
|
2020
Q3 | $261K | Sell |
4,391
-184
| -4% | -$12.6K | ﹤0.01% | 1475 |
|
|
2020
Q2 | $319K | Buy |
4,575
+24
| +0.5% | +$1.52K | ﹤0.01% | 1422 |
|
|
2020
Q1 | $206K | Sell |
4,551
-77
| -2% | -$4.36K | ﹤0.01% | 1440 |
|
|
2019
Q4 | $301K | Sell |
4,628
-793
| -15% | -$53K | ﹤0.01% | 1486 |
|
|
2019
Q3 | $336K | Buy |
+5,421
| New | +$340K | ﹤0.01% | 1407 |
|
|
2018
Q4 | – | Sell |
-11,256
| Closed | -$1.93M | – | 1668 |
|
|
2018
Q3 | $1.93M | Buy |
11,256
+88
| +0.8% | +$13.3K | 0.03% | 545 |
|
|
2018
Q2 | $1.44M | Buy |
11,168
+256
| +2% | +$28.6K | 0.03% | 601 |
|
|
2018
Q1 | $1.12M | Buy |
10,912
+4,168
| +62% | +$412K | 0.02% | 648 |
|
|
2017
Q4 | $576K | Buy |
6,744
+112
| +2% | +$9.71K | 0.01% | 743 |
|
|
2017
Q3 | $563K | Buy |
6,632
+610
| +10% | +$48.3K | 0.03% | 665 |
|
|
2017
Q2 | $456K | Buy |
6,022
+2,656
| +79% | +$186K | 0.03% | 461 |
|
|
2017
Q1 | $222K | Buy |
3,366
+64
| +2% | +$4.21K | 0.02% | 626 |
|
|
2016
Q4 | $209K | Buy |
+3,302
| New | +$208K | 0.02% | 422 |
|
Other funds holding LGND
CAM
CC
SIMG
RHJA
State of Alaska Department of Revenue's LGND Position: Q2 2026 in Review
State of Alaska Department of Revenue reduced its Ligand Pharmaceuticals (LGND) stake by 23% in Q2 2026, selling an estimated $736K and leaving 10,233 shares worth $3.23M. The position accounts for 0.03% of the portfolio, ranked #466.
State of Alaska Department of Revenue first reported a position in LGND in Q4 2016 and has held it in 36 quarters since. 271 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- State of Alaska Department of Revenue held 10,233 shares of Ligand Pharmaceuticals worth $3.23M as of Q2 2026.
- State of Alaska Department of Revenue sold 3,123 Ligand Pharmaceuticals shares in Q2 2026, an estimated $736K.
- Ligand Pharmaceuticals made up 0.03% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #466 holding.
- State of Alaska Department of Revenue first reported a position in Ligand Pharmaceuticals in Q4 2016 and has held it in 36 quarters since.
- 271 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.